Ninds center for clinical trial resources
Active Definitive Contract Awarded Last action
- Contract number
- 75N95022C00041
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,122,780
Award facts
- Opportunity
-
- NINDS Center for Clinical Trial Resources Pre-Solicitation · 75N95022R00014 · Posted Apr 11, 2022
- Contract value 100% obligated
- $9,122,779.51 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $97,050 | |
| Exercise an Option | $1,497,566 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,201,038 | |
| Exercise an Option | $1,970,467 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,909,098 | |
| Funding Only Action | $181,929 | |
| Original award | $1,265,632 |
About this award
The National Institute on Drug Abuse awarded a $9.1 million definitive contract to The Emmes Company, LLC for the NINDS Center for Clinical Trial Resources on September 30, 2022, under cost-plus-fixed-fee pricing with no set-aside.
The originating solicitation, posted April 11, 2022 with proposals due May 3, 2022, seeks scientific resources and services to support the clinical research program of the National Institute of Neurological Disorders and Stroke across four areas: quality assurance and quality control monitoring; statistical and methodological support; clinical data acquisition and archiving; and development of Common Data Elements. Place of performance is Rockville, MD. The contract carries a one-year base period and four one-year options, with ultimate completion on September 29, 2027.
Government-invoiced labor across FY2023–FY2025 totaled $4.5 million (7.0 FTEs in FY2025), with derived government-paid rates of $125.09 per hour in FY2023 and $119.76 per hour in FY2024. The Emmes Company self-performed all reported hours with no subcontractor engagement. Labor footprint has grown modestly year over year, from 4.1 FTEs and 8,528 hours in FY2023 to 7.0 FTEs in FY2025.
NAICS code 541715, PSC R425.
Quick answers
Who was awarded contract 75N95022C00041?
75N95022C00041 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2022.
How much is contract 75N95022C00041 worth?
The government has obligated $9,122,780 on 75N95022C00041.
Was contract 75N95022C00041 competed?
The extent of competition for 75N95022C00041 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award